Clinical Trial

Tunisian Lung Cancer Study

Study acronym: LUNG-TUN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-11.
Status change: Not Yet Recruiting → Recruiting 2025-06-02
Trial Details
NCT Number NCT06934499
Lead Sponsor Dacima Consulting
Collaborators: The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM), Tunisian Society of Respiratory Diseases and Allergology, Tunisian Society of Medical Oncology
Conditions Pulmonary Cancer
Enrollment 1,334 participants
Start Date 2025-05-02
Primary Completion 2025-10-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-04